CClinicalTrials.gg
CompletedNCT05177757Updated Sep 6, 2022

Feasibility of a Yoga Program for Veterans With PTSD

An interventional study of Yoga Intervention in Stress Disorders, Post-Traumatic, sponsored by Marquette University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-06.

Sponsored by Marquette University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study is designed to examine the feasibility of a 12-week yoga program on physiological and psychological health and its neurobiological mechanisms in N=15 veterans with posttraumatic stress disorder (PTSD). The investigators will be examining specific parameters of health and mechanisms before and after the yoga program.

02

Conditions studied

  • Stress Disorders, Post-Traumatic
03

In context

Stress Disorders, Post-Traumatic

2,239 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 554 are open to participants now.

This study's enrollment of 14 is below the median of 70 across 1,858 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Marquette University is the lead sponsor of 36 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • U.S. Military Veteran
  • 18 years of age or older
  • Diagnosis of PTSD as assessed by a score of >30 on the PTSD-Checklist Version 5 (PCL-5)
  • Willing and able to attend testing and yoga sessions at the Athletic and Human Research Performance Center (AHPRC) on the campus of Marquette University
  • Clear to participate in physical activity based on the Physical Activity Readiness Questionnaire (PARQ+)

Exclusion criteria

Exclusion Criteria:

  • Currently pregnant or trying to become pregnant
  • Positive score to one or more items on the PAR-Q+ without physician approval
  • Already established regular use of yoga (i.e., more than one day per week)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Yoga Intervention

    The yoga exercise program will be conducted at the Marquette campus and will consist of one session per week for 12 weeks. The duration of each session will be approximately one hour. The program the investigators will use is the Mindful Resilience for Trauma Recovery Program (https://www.veteransyogaproject.org/), an evidence-informed practice adapted for veterans with PTSD based on clinical and neuroscientific knowledge. This program is a 12-week protocol developed by a licensed clinical psychologist and is publicly available. All yoga sessions will be standardized based on the resilience program guidelines.

    Other: Yoga Intervention

Interventions

  • OtherYoga Intervention

    The yoga exercise program will be conducted at the Marquette campus and will consist of one session per week for 12 weeks. The duration of each session will be approximately one hour. The program the investigators will use is the Mindful Resilience for Trauma Recovery Program (https://www.veteransyogaproject.org/), an evidence-informed practice adapted for veterans with PTSD based on clinical and neuroscientific knowledge. This program is a 12-week protocol developed by a licensed clinical psychologist and is publicly available. All yoga sessions will be standardized based on the resilience program guidelines.

06

What researchers measure

Primary outcomes

  1. Endocannabinoid assay

    Endocannabinoid ligands reported in ng/ml

    Time frame: Change in ligands from baseline to12 weeks

  2. Cortisol assay

    Cortisol reported in μg/dL

    Time frame: Change in cortisol from baseline to12 weeks

  3. Cognitive functioning using a computerized battery

    Performance on cognitive tasks reported in accuracy and reaction time

    Time frame: Change in performance from baseline to12 weeks

  4. Body Mass Index (BMI)

    Body Mass Index (BMI) calculated by height and weight

    Time frame: Change in BMI from baseline to12 weeks

  5. Blood pressure

    Blood pressure reported in systolic and diastolic (mmHg)

    Time frame: Change in blood pressure from baseline to12 weeks

  6. Heart rate

    Heart rate reported in beats per minute (BPM)

    Time frame: Change in heart rate from baseline to12 weeks

  7. Heart rate variability (HRV)

    Heart rate variability (HRV) reported in the standard deviation of the RR intervals (distance between heartbeats) as quantified on standard electrocardiogram (ECG)

    Time frame: Change in HRV from baseline to12 weeks

  8. Lung functioning

    Lung functioning measured by spirometry reported in vital capacity (VC)

    Time frame: Change in lung functioning from baseline to12 weeks

  9. Range of motion

    Range of motion measured by goniometer reported in degrees

    Time frame: Change in range of motion from baseline to12 weeks

  10. Body composition

    Body composition measured by dual-energy x-ray absorptiometry (DEXA) reported in volume cubic meters (m3) and mass (kilograms)

    Time frame: Change in body composition from baseline to12 weeks

  11. Hand grip strength

    Hand grip strength measured by a dynamometer reported in pounds (lbs)

    Time frame: Change in hand grip strength from baseline to12 weeks

  12. Aerobic fitness

    Aerobic fitness measured by a submaximal graded exercise test reported in the volume of oxygen consumed (VO2)

    Time frame: Change in aerobic fitness from baseline to12 weeks

  13. Physical activity

    Physical activity measured by a accelerometer reported in change in velocity over time (meters per seconds)

    Time frame: Change in physical activity from baseline to12 weeks

  14. Severity of posttraumatic stress disorder (PTSD)

    Scores on the Clinician Administered PTSD Scale (CAPS-5) (range 0-80; higher scores indicate more severity)

    Time frame: Change in scores from baseline to12 weeks

  15. Frequency of physical activity

    Scores on the International Physical Activity Questionnaire-Short Form (IPAQ-SF) reported in hours and minutes each day

    Time frame: Change in scores from baseline to12 weeks

  16. Physical health rating

    Scores on the Medical Outcomes Study-Short Form (SF-36) (range 0-100; higher scores indicate better health outcome)

    Time frame: Change in scores from baseline to12 weeks

  17. Severity of sleep disturbance

    Scores on the Pittsburgh Sleep Quality Index (PSQI) (range 0-21; higher scores indicate worse sleep quality)

    Time frame: Change in scores from baseline to12 weeks

  18. Mindfulness rating

    Scores on the Five Facet Mindfulness Questionnaire (FFMQ) (range 39-195; higher scores indicate more mindfulness)

    Time frame: Change in scores from baseline to12 weeks

  19. Frequency of yoga rating

    Scores on the Yoga and Self-efficacy Scale (YSES) (range 12-108; higher scores indicate more engagement with yoga practices)

    Time frame: Change in scores from baseline to12 weeks

07

Study locations

1 site
  • Marquette University
    Milwaukee, Wisconsin 53207, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05177757
Lead sponsor
Marquette University
Responsible party
Jacklynn Fitzgerald (Assistant Professor, Marquette University) — Principal investigator
First posted
Jan 5, 2022
Start date
Jan 3, 2022
Primary completion
May 27, 2022
Completion
May 28, 2022
Last update
Sep 6, 2022

Study contacts

Jacklynn Fitzgerald, PhD
principal investigator · Marquette University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion